Literature DB >> 19805152

Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein.

Matti Kankainen1, Lars Paulin, Soile Tynkkynen, Ingemar von Ossowski, Justus Reunanen, Pasi Partanen, Reetta Satokari, Satu Vesterlund, Antoni P A Hendrickx, Sarah Lebeer, Sigrid C J De Keersmaecker, Jos Vanderleyden, Tuula Hämäläinen, Suvi Laukkanen, Noora Salovuori, Jarmo Ritari, Edward Alatalo, Riitta Korpela, Tiina Mattila-Sandholm, Anna Lassig, Katja Hatakka, Katri T Kinnunen, Heli Karjalainen, Maija Saxelin, Kati Laakso, Anu Surakka, Airi Palva, Tuomas Salusjärvi, Petri Auvinen, Willem M de Vos.   

Abstract

To unravel the biological function of the widely used probiotic bacterium Lactobacillus rhamnosus GG, we compared its 3.0-Mbp genome sequence with the similarly sized genome of L. rhamnosus LC705, an adjunct starter culture exhibiting reduced binding to mucus. Both genomes demonstrated high sequence identity and synteny. However, for both strains, genomic islands, 5 in GG and 4 in LC705, punctuated the colinearity. A significant number of strain-specific genes were predicted in these islands (80 in GG and 72 in LC705). The GG-specific islands included genes coding for bacteriophage components, sugar metabolism and transport, and exopolysaccharide biosynthesis. One island only found in L. rhamnosus GG contained genes for 3 secreted LPXTG-like pilins (spaCBA) and a pilin-dedicated sortase. Using anti-SpaC antibodies, the physical presence of cell wall-bound pili was confirmed by immunoblotting. Immunogold electron microscopy showed that the SpaC pilin is located at the pilus tip but also sporadically throughout the structure. Moreover, the adherence of strain GG to human intestinal mucus was blocked by SpaC antiserum and abolished in a mutant carrying an inactivated spaC gene. Similarly, binding to mucus was demonstrated for the purified SpaC protein. We conclude that the presence of SpaC is essential for the mucus interaction of L. rhamnosus GG and likely explains its ability to persist in the human intestinal tract longer than LC705 during an intervention trial. The presence of mucus-binding pili on the surface of a nonpathogenic Gram-positive bacterial strain reveals a previously undescribed mechanism for the interaction of selected probiotic lactobacilli with host tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805152      PMCID: PMC2746127          DOI: 10.1073/pnas.0908876106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.

Authors:  Charles A Whittaker; Richard O Hynes
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

2.  Detecting pathogenicity islands and anomalous gene clusters by iterative discriminant analysis.

Authors:  Qiang Tu; Dafu Ding
Journal:  FEMS Microbiol Lett       Date:  2003-04-25       Impact factor: 2.742

3.  Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.

Authors:  Minna K Salminen; Soile Tynkkynen; Hilpi Rautelin; Maija Saxelin; Martti Vaara; Petri Ruutu; Seppo Sarna; Ville Valtonen; Asko Järvinen
Journal:  Clin Infect Dis       Date:  2002-10-21       Impact factor: 9.079

4.  Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans.

Authors:  C N Jacobsen; V Rosenfeldt Nielsen; A E Hayford; P L Møller; K F Michaelsen; A Paerregaard; B Sandström; M Tvede; M Jakobsen
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

5.  Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG.

Authors:  S L Gorbach; T W Chang; B Goldin
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

6.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.

Authors:  M Kalliomäki; S Salminen; H Arvilommi; P Kero; P Koskinen; E Isolauri
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

7.  Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.

Authors:  K Hatakka; E Savilahti; A Pönkä; J H Meurman; T Poussa; L Näse; M Saxelin; R Korpela
Journal:  BMJ       Date:  2001-06-02

Review 8.  Genetics of bacteriocins produced by lactic acid bacteria.

Authors:  T R Klaenhammer
Journal:  FEMS Microbiol Rev       Date:  1993-09       Impact factor: 16.408

9.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro.

Authors:  D R Mack; S Ahrne; L Hyde; S Wei; M A Hollingsworth
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

10.  Identification of a Gene Cluster for the Biosynthesis of a Long, Galactose-Rich Exopolysaccharide in Lactobacillus rhamnosus GG and Functional Analysis of the Priming Glycosyltransferase.

Authors:  Sarah Lebeer; Tine L A Verhoeven; Grégory Francius; Geert Schoofs; Ivo Lambrichts; Yves Dufrêne; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

View more
  250 in total

Review 1.  Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut.

Authors:  Marco Ventura; Francesca Turroni; Douwe van Sinderen
Journal:  Bioeng Bugs       Date:  2012-03-01

2.  Draft genome sequence of probiotic strain Lactobacillus rhamnosus R0011.

Authors:  Thomas A Tompkins; Guillaume Barreau; Vanessa G de Carvalho
Journal:  J Bacteriol       Date:  2012-02       Impact factor: 3.490

3.  Whole-genome shotgun sequencing of Lactobacillus rhamnosus MTCC 5462, a strain with probiotic potential.

Authors:  J B Prajapati; C D Khedkar; J Chitra; Senan Suja; V Mishra; V Sreeja; R K Patel; V B Ahir; V D Bhatt; M R Sajnani; S J Jakhesara; P G Koringa; C G Joshi
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

4.  Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.

Authors:  Ingemar von Ossowski; Justus Reunanen; Reetta Satokari; Satu Vesterlund; Matti Kankainen; Heikki Huhtinen; Soile Tynkkynen; Seppo Salminen; Willem M de Vos; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

5.  The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions.

Authors:  Malin E V Johansson; Jessica M Holmén Larsson; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

6.  Metatranscriptome analysis for insight into whole-ecosystem gene expression during spontaneous wheat and spelt sourdough fermentations.

Authors:  Stefan Weckx; Joke Allemeersch; Roel Van der Meulen; Gino Vrancken; Geert Huys; Peter Vandamme; Paul Van Hummelen; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

7.  Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG.

Authors:  Kerttu Koskenniemi; Kati Laakso; Johanna Koponen; Matti Kankainen; Dario Greco; Petri Auvinen; Kirsi Savijoki; Tuula A Nyman; Anu Surakka; Tuomas Salusjärvi; Willem M de Vos; Soile Tynkkynen; Nisse Kalkkinen; Pekka Varmanen
Journal:  Mol Cell Proteomics       Date:  2010-11-15       Impact factor: 5.911

8.  Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging.

Authors:  Francesca Turroni; Francesca Bottacini; Elena Foroni; Imke Mulder; Jae-Han Kim; Aldert Zomer; Borja Sánchez; Alessandro Bidossi; Alberto Ferrarini; Vanessa Giubellini; Massimo Delledonne; Bernard Henrissat; Pedro Coutinho; Marco Oggioni; Gerald F Fitzgerald; David Mills; Abelardo Margolles; Denise Kelly; Douwe van Sinderen; Marco Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 9.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

Review 10.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.